Not recruiting
Immunodeficiency common variable
Not recruitingA Study of Leniolisib Safety and Effectiveness for Immune System Problems in Patients with Common Variable Immunodeficiency
InvestigationalNo placebo
A Study of Leniolisib Safety and Effectiveness for Immune System Problems in Patients with Common Variable Immunodeficiency
InvestigationalNo placebo
- Disease:Immunodeficiency common variable
- Substances:Leniolisib Phosphate
Countries:
Spain
Spain- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Leniolisib Phosphate
- Sponsor:Pharming Technologies B.V.


